ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,281 | -16.5% | 2,275 | 0.0% | 0.00% | – |
| Q2 2021 | $9,919 | +6.1% | 2,275 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $9,350 | +3.0% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,077 | +47.8% | 2,275 | 0.0% | 0.00% | – |
| Q3 2020 | $6,143 | -1.8% | 2,275 | 0.0% | 0.00% | – |
| Q2 2020 | $6,256 | +16.5% | 2,275 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $5,369 | -49.8% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,693 | +40.5% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,610 | +1.7% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $7,485 | +8.6% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,893 | +11.4% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $6,188 | -19.0% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $7,644 | +30.2% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $5,870 | +17.3% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,005 | +10.6% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,527 | -38.6% | 2,275 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $7,371 | – | 2,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |